CIBC Bancorp USA’s Astera Labs ALAB Stock Holding History

CIBC Bancorp USA’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.45M	Sell	13,412 -4,667	-26%	-$1.24M	0.01%	667
2026 Q1	$1.98M	Buy	+18,079	New	+$2.58M	﹤0.01%	908

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIBC Bancorp USA's ALAB Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Astera Labs (ALAB) stake by 26% in Q2 2026, selling an estimated $1.24M and leaving 13,412 shares worth $6.45M. The position accounts for 0.01% of the portfolio, ranked #667.

CIBC Bancorp USA first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

CIBC Bancorp USA held 13,412 shares of Astera Labs worth $6.45M as of Q2 2026.
CIBC Bancorp USA sold 4,667 Astera Labs shares in Q2 2026, an estimated $1.24M.
Astera Labs made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #667 holding.
CIBC Bancorp USA first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.